news_image.jpg

FGF23 affects mortality and cardiovascular risks in type 2 diabetes

07 Oct 2019



High levels of fibroblast growth factor 23 (FGF23) is associated with increased cardiovascular and mortality risks in people with type 2 diabetes with normal or mildly impaired kidney function, according to findings published in Diabetes Care.

Healio



Issue 45 - Autumn 2019 - ESPE 2019 in Vienna

Latest Newsletter

Issue 45 - Autumn 2019 - ESPE 2019 in Vienna

Issue 45 - Autumn 2019 - ESPE 2019 in Vienna

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive